|
84
|
330
|
4y4bA |
Endothiapepsin in complex with fragment 323 |
|
91
|
339
|
4xx4A |
Renin in complex with (4s)-4-isopropyl-4-methyl-6-oxo-1-(3-(2-oxo-4-phenylpyrrolidin-1-yl)benzyl)tetrahydropyrimidin-2(1h)-iminium |
|
84
|
330
|
4y45A |
Endothiapepsin in complex with fragment 291 |
|
88
|
330
|
4y4xA |
Endothiapepsin in complex with fragment 51 |
|
83
|
330
|
4y3eA |
Endothiapepsin in complex with fragment 5 |
|
82
|
330
|
4y48A |
Endothiapepsin in complex with fragment b50 |
|
99
|
387
|
4xkxA |
Crystal structure of bace1 in complex with 2-aminooxazoline 3-azaxanthene inhibitor 28 |
|
78
|
330
|
4y4gA |
Endothiapepsin in complex with fragment b53 |
|
82
|
330
|
4y41A |
Endothiapepsin in complex with fragment 112 |
|
84
|
330
|
4y4wA |
Endothiapepsin in complex with fragment 125 |
|
83
|
330
|
4y5eA |
Endothiapepsin in complex with fragment 268 |
|
85
|
330
|
4y3rA |
Endothiapepsin in complex with fragment 306 |
|
85
|
330
|
4y44A |
Endothiapepsin in complex with fragment 164 |
|
86
|
330
|
4y3pA |
Endothiapepsin in complex with fragment 17 |
|
78
|
330
|
4y4jA |
Endothiapepsin in complex with fragment b97 |
|
84
|
330
|
4y5nA |
Endothiapepsin in complex with fragment 337 |
|
85
|
330
|
4y5kA |
Endothiapepsin in complex with fragment 274 |
|
83
|
330
|
4y57A |
Endothiapepsin in complex with fragment 63 |
|
78
|
330
|
4y5lA |
Endothiapepsin in its apo form |
|
88
|
330
|
4y53A |
Endothiapepsin in complex with fragment 54 |
|
82
|
330
|
4y3dA |
Endothiapepsin in complex with fragment 321 |
|
85
|
330
|
4y3zA |
Endothiapepsin in complex with fragment 41 |
|
90
|
339
|
4xx3A |
Renin in complex with (s)-1-(3-(benzylcarbamoyl)benzyl)-4-isopropyl-4-methyl-6-oxotetrahydropyrimidin-2(1h)-iminium |
|
83
|
330
|
4y39A |
Endothiapepsin in complex with fragment 75 |
|
86
|
330
|
4y3hA |
Endothiapepsin in complex with fragment 189 |
|
102
|
387
|
4wtuA |
Crystal structure of bace1 in complex with 2-aminooxazoline 3-aza-4-fluoro-xanthene inhibitor 22 |
|
101
|
390
|
4x7iA |
Crystal structure of bace with amino thiazine inhibitor ly2886721 |
|
96
|
389
|
4x2lA |
Crystal structure of human bace-1 bound to compound 6 |
|
102
|
400
|
4wy1A |
Crystal structure of human bace-1 bound to compound 24b |
|
95
|
389
|
4wy6A |
Crystal structure of human bace-1 bound to compound 36 |
|
94
|
389
|
4trwA |
Structure of bace1 complex with a syn-hea-type inhibitor |
|
89
|
339
|
4rygA |
Renin in complexed with n-({(3s,4s)-4-[(benzylsulfonyl)amino]pyrrolidin-3-yl}methyl)-4-methoxy-3-(3-methoxypropoxy)-n-(propan-2-yl)benzamide inhibitor |
|
105
|
400
|
4rroA |
8-tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzyme 1 (bace1) inhibitors |
|
98
|
387
|
4tryA |
Structure of bace1 complex with a hea-type inhibitor |
|
90
|
339
|
4rz1A |
Renin in complexed with (3s,4s)-4-({[4-methoxy-3-(3-methoxypropoxy)benzoyl](propan-2-yl)amino}methyl)pyrrolidin-3-yl benzylcarbamate inhibitor |
|
105
|
400
|
4rrnA |
8-tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzyme 1 (bace1) inhibitors |
|
91
|
339
|
4s1gA |
Renin in complex with (s)-1-(3-fluoro-5-(((s)-1-phenylethyl)carbamoyl)benzyl)-4-isopropyl-4-methyl-6-oxotetrahydropyrimidin-2(1h)-iminium |
|
106
|
400
|
4rrsA |
8-tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzyme 1 (bace1) inhibitors |
|
78
|
388
|
4trzA |
Structure of bace1 complex with 2-thiophenyl hea-type inhibitor |
|
88
|
339
|
4rycA |
Renin in complexed with 4-methoxy-3-(3-methoxypropoxy)-n-{[(3s,4s)-4-{[(4-methylphenyl)sulfonyl]amino}pyrrolidin-3-yl]methyl}-n-(propan-2-yl)benzamide inhibitor |
|
95
|
387
|
4rceA |
Crystal structure of bace1 in complex with aminooxazoline xanthene inhibitor 2 |
|
105
|
389
|
4r93A |
Bace-1 in complex with (r)-4-(2-cyclohexylethyl)-1-methyl-5-oxo-4-(((1s,3r)-3-(3-phenylureido)cyclohexyl)methyl)imidazolidin-2-iminium |
|
106
|
390
|
4r91A |
Bace-1 in complex with (r)-4-(2-cyclohexylethyl)-4-(((1s,3r)-3-(cyclopentylamino)cyclohexyl)methyl)-1-methyl-5-oxoimidazolidin-2-iminium |
|
107
|
390
|
4r8yA |
Bace-1 in complex with (r)-4-(2-cyclohexylethyl)-4-(((r)-1-(2-cyclopentylacetyl)pyrrolidin-3-yl)methyl)-1-methyl-5-oxoimidazolidin-2-iminium |
|
103
|
390
|
4r95A |
Bace-1 in complex with 2-(((1r,3s)-3-(((r)-4-(2-cyclohexylethyl)-2-iminio-1-methyl-5-oxoimidazolidin-4-yl)methyl)cyclohexyl)amino)quinolin-1-ium |
|
101
|
388
|
4rcfA |
Crystal structure of bace1 in complex with 2-aminooxazoline 4-fluoroxanthene inhibitor 49 |
|
96
|
387
|
4rcdA |
Crystal structure of bace1 in complex with a 2-aminooxazoline 4-azaxanthene inhibitor |
|
101
|
391
|
4r92A |
Bace-1 in complex with (r)-4-(2-cyclohexylethyl)-4-(((1s,3r)-3-(isonicotinamido)cyclohexyl)methyl)-1-methyl-5-oxoimidazolidin-2-iminium |
|
106
|
400
|
4r5nA |
8-tetrahydropyran-2-yl chromans: highly selective beta-site amyloid precursor protein cleaving enzyme 1 (bace1) inhibitors |
|
84
|
330
|
4rldA |
Crystal structure of kkf mutant of bla g 2 protein |
